Perceptive Advisors as of Dec. 31, 2018
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 98 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Neurocrine Biosciences (NBIX) | 12.3 | $315M | 4.6M | 68.43 | |
| Global Blood Therapeutics In | 8.7 | $223M | 5.4M | 41.05 | |
| Amicus Therapeutics (FOLD) | 7.5 | $192M | 21M | 9.25 | |
| Zogenix | 5.7 | $146M | 4.0M | 36.46 | |
| Iovance Biotherapeutics (IOVA) | 4.2 | $108M | 12M | 8.85 | |
| Crinetics Pharmaceuticals In (CRNX) | 3.0 | $78M | 2.6M | 29.99 | |
| Quotient | 2.6 | $66M | 11M | 6.12 | |
| Amarin Corporation (AMRN) | 2.5 | $65M | 4.9M | 13.24 | |
| Ascendis Pharma A S (ASND) | 2.5 | $63M | 1.1M | 59.89 | |
| Arena Pharmaceuticals | 2.2 | $56M | 1.4M | 38.88 | |
| Argenx Se (ARGX) | 2.1 | $54M | 561k | 96.07 | |
| Myokardia | 2.1 | $54M | 1.1M | 49.76 | |
| Merit Medical Systems (MMSI) | 2.0 | $52M | 949k | 54.97 | |
| Retrophin | 1.9 | $50M | 3.3M | 14.90 | |
| Meiragtx Holdings (MGTX) | 1.8 | $45M | 4.7M | 9.64 | |
| Blueprint Medicines (BPMC) | 1.7 | $44M | 857k | 50.72 | |
| Cytomx Therapeutics (CTMX) | 1.7 | $44M | 2.9M | 14.97 | |
| Allogene Therapeutics (ALLO) | 1.6 | $42M | 1.5M | 26.93 | |
| La Jolla Pharmaceuticl Com Par | 1.6 | $41M | 4.3M | 9.51 | |
| Acceleron Pharma | 1.6 | $40M | 905k | 44.13 | |
| Albireo Pharma | 1.5 | $40M | 1.7M | 23.18 | |
| Vbi Vaccines | 1.5 | $38M | 24M | 1.60 | |
| Athenex | 1.3 | $33M | 5.1M | 6.39 | |
| Momenta Pharmaceuticals | 1.2 | $31M | 2.8M | 11.02 | |
| Solid Biosciences | 1.2 | $30M | 3.9M | 7.63 | |
| Verrica Pharmaceuticals (VRCA) | 1.1 | $28M | 3.4M | 8.15 | |
| Kadmon Hldgs | 1.1 | $27M | 13M | 2.08 | |
| Regenxbio Inc equity us cm (RGNX) | 1.1 | $27M | 646k | 41.65 | |
| Aldeyra Therapeutics (ALDX) | 1.0 | $25M | 3.1M | 8.00 | |
| Vapotherm | 0.9 | $25M | 1.2M | 19.95 | |
| Dova Pharmaceuticals | 0.9 | $24M | 3.1M | 7.58 | |
| Concert Pharmaceuticals I equity | 0.9 | $23M | 1.9M | 12.18 | |
| Kodiak Sciences (KOD) | 0.9 | $22M | 3.1M | 7.10 | |
| Viewray (VRAYQ) | 0.8 | $22M | 3.9M | 5.56 | |
| Invitae (NVTAQ) | 0.8 | $21M | 1.9M | 11.06 | |
| Cymabay Therapeutics | 0.8 | $19M | 2.5M | 7.87 | |
| Alnylam Pharmaceuticals (ALNY) | 0.7 | $19M | 262k | 70.40 | |
| Neptune Wellness Solutions I | 0.7 | $18M | 8.9M | 2.01 | |
| Clementia | 0.7 | $18M | 1.5M | 11.76 | |
| Foamix Pharmaceuticals | 0.6 | $16M | 4.7M | 3.40 | |
| Establishment Labs Holdings Ord (ESTA) | 0.6 | $16M | 614k | 25.85 | |
| Adma Biologics (ADMA) | 0.6 | $15M | 6.5M | 2.23 | |
| Rhythm Pharmaceuticals (RYTM) | 0.5 | $14M | 509k | 27.03 | |
| Immunomedics | 0.5 | $14M | 900k | 15.00 | |
| Aquestive Therapeutics | 0.5 | $13M | 2.1M | 6.30 | |
| Sage Therapeutics (SAGE) | 0.5 | $13M | 147k | 88.99 | |
| Mei Pharma | 0.5 | $12M | 4.4M | 2.64 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.4 | $11M | 723k | 15.57 | |
| Marker Therapeutics Ord | 0.4 | $11M | 2.0M | 5.55 | |
| Axonics Modulation Technolog (AXNX) | 0.4 | $11M | 751k | 14.56 | |
| Motus Gi Hldgs Incorporated | 0.4 | $10M | 3.2M | 3.11 | |
| Eidos Therapeutics | 0.4 | $9.5M | 687k | 13.76 | |
| Akebia Therapeutics (AKBA) | 0.4 | $9.2M | 1.7M | 5.39 | |
| Protagonist Therapeutics | 0.4 | $9.2M | 1.4M | 6.73 | |
| Orchard Therapeutics Plc ads | 0.3 | $8.2M | 522k | 15.73 | |
| Ani Pharmaceuticals Inc. note 3.000 12/0 | 0.3 | $7.4M | 7.5M | 0.98 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.3 | $7.4M | 445k | 16.57 | |
| Zymeworks | 0.3 | $7.2M | 574k | 12.54 | |
| Molecular Templates | 0.3 | $7.1M | 2.0M | 3.60 | |
| Xencor (XNCR) | 0.3 | $6.8M | 197k | 34.72 | |
| Synlogic | 0.2 | $6.0M | 868k | 6.97 | |
| Uniqure Nv (QURE) | 0.2 | $5.9M | 221k | 26.94 | |
| Therapeuticsmd | 0.2 | $5.7M | 1.5M | 3.81 | |
| Dbv Technologies S A (DBVT) | 0.2 | $5.3M | 827k | 6.42 | |
| Mirati Therapeutics | 0.2 | $5.3M | 126k | 41.71 | |
| Urovant Sciences | 0.1 | $3.9M | 625k | 6.26 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.1 | $3.6M | 300k | 11.94 | |
| Rocket Pharmaceuticals (RCKT) | 0.1 | $3.5M | 240k | 14.55 | |
| Sierra Oncology | 0.1 | $3.4M | 2.7M | 1.28 | |
| Teladoc (TDOC) | 0.1 | $3.0M | 60k | 49.57 | |
| Translate Bio | 0.1 | $3.2M | 435k | 7.28 | |
| Wave Life Sciences (WVE) | 0.1 | $2.5M | 60k | 42.04 | |
| eHealth (EHTH) | 0.1 | $2.1M | 55k | 38.40 | |
| Penumbra (PEN) | 0.1 | $2.0M | 16k | 124.68 | |
| Female Health (VERU) | 0.1 | $1.9M | 1.4M | 1.30 | |
| Acasti Pharma | 0.1 | $1.5M | 1.8M | 0.83 | |
| Eiger Biopharmaceuticals | 0.1 | $1.4M | 140k | 10.16 | |
| Oncomed Pharmaceuticals | 0.1 | $1.3M | 1.7M | 0.75 | |
| Abeona Therapeutics | 0.1 | $1.3M | 181k | 7.02 | |
| Abeona Therapeutics Inc *w exp 12/19/201 | 0.1 | $1.3M | 660k | 1.92 | |
| Caredx (CDNA) | 0.0 | $1.0M | 44k | 23.50 | |
| Adverum Biotechnologies | 0.0 | $960k | 300k | 3.20 | |
| Invacare Corporation | 0.0 | $860k | 200k | 4.30 | |
| Fiat Chrysler Auto | 0.0 | $894k | 62k | 14.42 | |
| Allena Pharmaceuticals | 0.0 | $704k | 132k | 5.32 | |
| STAAR Surgical Company (STAA) | 0.0 | $405k | 13k | 31.27 | |
| Amedisys (AMED) | 0.0 | $422k | 3.7k | 114.92 | |
| Dex (DXCM) | 0.0 | $442k | 3.7k | 118.40 | |
| Vericel (VCEL) | 0.0 | $488k | 28k | 17.37 | |
| Glaukos (GKOS) | 0.0 | $417k | 7.5k | 55.85 | |
| Ferrari Nv Ord (RACE) | 0.0 | $610k | 6.2k | 98.39 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.0 | $640k | 1.0M | 0.64 | |
| Tandem Diabetes Care (TNDM) | 0.0 | $479k | 13k | 37.29 | |
| Alliqua Biomedical | 0.0 | $215k | 115k | 1.87 | |
| Vaccinex | 0.0 | $190k | 50k | 3.80 | |
| Si-bone (SIBN) | 0.0 | $307k | 15k | 20.47 | |
| Oncosec Med | 0.0 | $32k | 50k | 0.64 | |
| Outlook Therapeutics Inc *w exp 02/18/201 | 0.0 | $72k | 421k | 0.17 |
